TGA Approval

VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial (398631)

ARTG ID

398631

ARTG Name

VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial

Sponsor

Celltrion Healthcare Australia Pty Ltd

ARTG Date

September 5, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Celltrion Healthcare Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/fe841d546e56b2f4e87fb0adc5a5314e.pdf

https://medical-cdn.nocode.com/drug_tga/5a6ad54ceab51c192cdc8b8d1a2fe661.pdf

Ingredient Name

Bevacizumab

Empowering clinical research with data-driven insights and AI-powered tools.

VEGZELMA bevacizumab 100 mg/ 4 mL solution for intravenous infusion, vial (398631) - TGA 批准文号 | MedPath